Cannabis Report
Home > Boards > US Listed > Biotechs > Advaxis, Inc. (ADXS)

Great question, Jess. I Will wait for Dew

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
trading_cyclist Member Profile
Member Level 
Followed By 27
Posts 3,441
Boards Moderated 0
Alias Born 03/08/14
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/14/2018 4:32:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2018 7:30:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2018 6:40:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2018 6:40:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2018 6:39:52 PM
Advaxis Announces Dosing of First Patient with ADXS-NEO, an Investigational Customized Immunotherapy Approach Targeting Perso... Business Wire - 6/11/2018 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2018 4:34:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/8/2018 4:34:25 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/8/2018 4:32:38 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 6/7/2018 9:17:22 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2018 9:12:35 AM
Advaxis Announces Prioritization of Product Portfolio and Reports Fiscal 2018 Second Quarter Financial Results Business Wire - 6/7/2018 9:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/6/2018 8:31:48 AM
Advaxis Appoints Molly Henderson as Chief Financial Officer Business Wire - 6/6/2018 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2018 4:32:08 PM
Data Highlighting Advaxis’ ADXS-PSA Presented at ASCO Annual Meeting Business Wire - 6/1/2018 8:00:00 AM
Advaxis to Host Business Update and Second Quarter 2018 Financial Results Conference Call on June 7, 2018 Business Wire - 5/31/2018 8:00:00 AM
Recently Presented Preclinical Data Show Potential for ADXS-NEO as Anti-Cancer Immunotherapy Agent Business Wire - 5/11/2018 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2018 5:30:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/25/2018 4:47:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/25/2018 4:47:20 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/25/2018 4:32:58 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/25/2018 4:32:29 PM
Traders News Issues Research, Growing Companies with New Product Development Catalysts InvestorsHub NewsWire - 4/24/2018 8:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/23/2018 5:33:37 PM
trading_cyclist Member Level  Friday, 11/10/17 10:22:00 PM
Re: Jesspro post# 42565
Post # of 72208 
Great question, Jess. I Will wait for Dew to reply before chiming in, but I think you've zeroed in on a critical issue.

Dew??

TC



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist